Reduced thrombin generation increases host susceptibility to group A streptococcal infection.
Bacterial plasminogen activators are commonplace among microbial pathogens, implying a central role of host plasmin in supporting bacterial virulence. Group A streptococci (GAS) secrete streptokinase, a specific activator of human plasminogen (PLG). The critical contribution of the streptokinase-PLG interaction to GAS pathogenicity was recently demonstrated using mice expressing human PLG. To examine the importance of thrombin generation in antimicrobial host defense, we challenged mice with deficiency of factor V (FV) in either the plasma or platelet compartment. Reduction of FV in either pool resulted in markedly increased mortality after GAS infection, with comparison to heterozygous F5-deficient mice suggesting a previously unappreciated role for the platelet FV pool in host defense. Mice with complete deficiency of fibrinogen also demonstrated markedly increased mortality to GAS infection relative to controls. Although FV Leiden may be protective in the setting of severe sepsis in humans, no significant survival advantage was observed in GAS-infected mice carrying the FV Leiden mutation. Taken together, our data support the hypothesis that local thrombosis/fibrin deposition limits the survival and dissemination of at least a subset of microbial pathogens and suggest that common variation in hemostatic factors among humans could affect host susceptibility to a variety of infectious diseases.
Sun
Hongmin
H
Department of Internal Medicine, University of Missouri-Columbia, USA.
Wang
Xixi
X
Degen
Jay L
JL
Ginsburg
David
D
D000818:Animals; D004198:Disease Susceptibility; D005165:Factor V / Q000502:physiology; D005260:Female; D005340:Fibrinogen / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D011517:Prothrombin Time; D013290:Streptococcal Infections / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000254:growth & development / Q000378:metabolism* / Q000472:pathogenicity*; D013300:Streptokinase / Q000378:metabolism; D015996:Survival Rate; D013917:Thrombin / Q000378:metabolism*
C095381:factor V Leiden; D005165:Factor V; D005340:Fibrinogen; D013300:Streptokinase; D013917:Thrombin